Novartis Close to Settling Kickback Violations, Filing Inadvertently Shows

Swiss pharma giant Novartis is closer to resolving six-year-old kickback charges with the U.S. government. The negotiations had been privately ongoing, but a recent letter that was accidentally published reveals the case may soon be concluded.